Assessing the efficacy of various treatment regimens for patients with endocrine ophthalmopathy associated with Graves’ disease [PDF]
Yu.V. Buldygina +6 more
openalex +1 more source
Commentary: Efficacy and safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ ophthalmopathy: a systematic review and meta-analysis [PDF]
Lingxiao Li, Jihong Wu
openalex +1 more source
Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists [PDF]
Alessandro Antonelli +6 more
openalex +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
Bonny M +6 more
europepmc +1 more source
Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]
Ma Z +7 more
europepmc +1 more source
Pulsatile ocular blood flow in patients with Graves' ophthalmopathy [PDF]
Chieh‐Chih Tsai +6 more
openalex +1 more source
New-Onset Graves' Ophthalmopathy After Treatment with Pembrolizumab: A Case Report and a Review of the Literature. [PDF]
Pan M, Zhou X, Wu Y.
europepmc +1 more source

